Active Ingredient: FOSCARBIDOPA; FOSLEVODOPA
Proprietary Name: VYALEV
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216962
Product Number: 001
Approval Date: Oct 16, 2024
Applicant Holder Full Name: ABBVIE INC
Marketing Status:
Prescription
Patent and Exclusivity Information
